Compare WHWK & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHWK | NIU |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 200.8M |
| IPO Year | 2017 | 2018 |
| Metric | WHWK | NIU |
|---|---|---|
| Price | $4.73 | $2.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.50 | $3.50 |
| AVG Volume (30 Days) | ★ 431.8K | 224.5K |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,145,000.00 | N/A |
| Revenue This Year | N/A | $25.54 |
| Revenue Next Year | N/A | $17.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $1.93 |
| 52 Week High | $5.50 | $5.67 |
| Indicator | WHWK | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 62.74 | 34.52 |
| Support Level | $3.79 | N/A |
| Resistance Level | $4.84 | $2.40 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 86.80 | 6.19 |
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.